Sign in
Not yet recruitingNo phase

Home computer eye exercises for older adults with mild cognitive impairment

Tests nLIFE EyeFitness home exercises in older people with mild cognitive impairment.

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment
Status
Not yet recruiting
People taking part
24 people, planned
Started
1 May 2025
Expected to end
28 Feb 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • nLIFE EyeFitness
Record updated
24 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 60 to 75 with amnestic mild cognitive impairment (aMCI), a mild memory problem. It tests home computer training for vision and thinking with nLIFE EyeFitness.

Age
60 to 75 years
Sex
All sexes
Disease stage
Diagnosis of amnestic mild cognitive impairment (aMCI).

Main reasons for not taking part

  • History of dementia
  • Diabetes mellitus or high blood pressure that is not under control
  • Diagnosis of major depression
  • Glaucoma or age-related macular degeneration
  • Clouding in the eye or retina and vitreous problems that block a correct eye check

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patients aged ≥ 60 years with a diagnosis of aMCI
  • Signing of informed consent

Who cannot take part

  • History of dementia
  • Diabetes mellitus
  • Uncontrolled hypertension
  • • Failure to obtain informed consent
  • Age <60 years
  • Age-related macular degeneration
  • Diagnosis of major depression
  • Glaucoma
  • Media opacity and vitreoretinal pathologies that may preclude a correct evaluation

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 60 and 75 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Globally, approximately 55 million people suffer from dementia, and 60-70% of cases are due to Alzheimer's disease (AD). Increasing scientific evidence highlights that the pathological changes underlying AD and other forms of dementia begin long before the onset of symptoms. Mild cognitive impairment (MCI) is a clinical condition that in people over 65 shows a prevalence ranging from 3% to 22%. The characteristics of MCI are the presence of a subjective memory disorder and a reduced ability to learn new information with normal general cognitive functioning, normal ability to perform daily activities and the absence of other conditions, such as depression, that could justify the memory disorder. Currently, the diagnosis of MCI is based exclusively on clinical evaluation, including neuropsychological tests.

Read full original descriptionShow less

Currently, there are no therapies available to prevent and/or treat dementia and the options for intervention are represented by treatments such as physical exercise and cognitive treatment. These practices refer to the concept of cognitive reserve. Computerized cognitive training (CCT) is characterized by being a personalized intervention, allows multi-domain training and increases the cognitive processes of patients with MCI. The National Low Vision Center has been using a software called nLIFE EyeFitness for several years, certified as a Class I Medical device. It allows you to carry out individualized rehabilitation exercises at home, using your own PC or tablet, with monitoring by the Center's operators. The exercises currently present stimulate attention, short-term visual memory, reaction time, executive function, working memory and, therefore, also appear suitable for stimulating subjects with MCI.

The 2 groups in the trial

  • SperimentalTreatment being tested

    All patients will undergo: * Standardized battery of tests for the diagnosis of cognitive decline corresponding to the BDM (Battery for Mental Deterioration * Global assessment measure of cognitive status (Minimal Mental State Examination - MMSE) * Complete eye examination * Tonometry * Visual acuity for distance (ETDRS) and near (MNRead) * Reading speed (IrestTEST) * Microperimetry * Psychological evaluation * Patients with visual impairment randomized to receive neurovisual rehabilitation treatment will carry out neurosensory rehabilitation remotely.

    Treatment: nLIFE EyeFitness

  • ControlNo study treatment, for comparison

    All patients will undergo: * Standardized battery of tests for the diagnosis of cognitive decline corresponding to the BDM (Battery for Mental Deterioration * Global assessment measure of cognitive status (Minimal Mental State Examination - MMSE) * Complete eye examination * Tonometry * Visual acuity for distance (ETDRS) and near (MNRead) * Reading speed (IrestTEST) * Microperimetry * Psychological evaluation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment: Effects of Sensorineural Telerahabilitation
Plain-language title
Home computer eye exercises for older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06942728, who can take part
Record updated
24 April 2025